10-K Decoder · All companies

AbbVie Inc.

ABBV · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$61.2B$56.3B+8.6%
Operating income$15.1B$9.14B+65.0%
Net income$4.19B$4.24B−1.2%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$17.4B$15.8B+10.3%
Operating income$6.27B$1.90B+229%
Net income$4.22B$186M+2,168%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was AbbVie's revenue in FY2025?
$61.2B in FY2025 (Fiscal year ended Dec 31, 2025), +8.6% vs $56.3B a year earlier, per its 10-K filed Feb 2026.
Was AbbVie profitable in FY2025?
Yes: net income was $4.19B and operating income $15.1B in FY2025.
What was AbbVie's revenue in Q3 2026?
$17.4B (+10.3% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.